Differences between familial and sporadic cases of vitiligo

Background  Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history. Objective  The aim of our study was to describe differences between familial and sporadic cases of vitiligo. Methods  A total of 186 adult vitiligo patients were examined, in 173 of whom t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2012-07, Vol.26 (7), p.915-918
Hauptverfasser: Karelson, M., Silm, H., Salum, T., Kõks, S., Kingo, K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 918
container_issue 7
container_start_page 915
container_title Journal of the European Academy of Dermatology and Venereology
container_volume 26
creator Karelson, M.
Silm, H.
Salum, T.
Kõks, S.
Kingo, K.
description Background  Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history. Objective  The aim of our study was to describe differences between familial and sporadic cases of vitiligo. Methods  A total of 186 adult vitiligo patients were examined, in 173 of whom the level of thyroid peroxidase antibodies, gastric parietal cell antibodies (PCA), antinuclear antibodies (ANA), anti‐adrenal cortex antibodies and rheumatoid factor in blood was measured. All patients were divided in two groups: the cases with positive family history of vitiligo (51) and the sporadic cases (135). Results  The risk of onset of the disease up to 20 years of age was higher in the familial group (P = 0.008). Patients in familial group showed more widespread depigmentation compared with sporadic cases [body surface area (BSA) over 10%: P = 0.004; BSA over 50%: P = 0.001]. In familial group, patients had darker skin phototype (P = 0.045) and the disease had started more often as a vulgar vitiligo (P = 0.008). In sporadic vitiligo group, female gender was a risk factor for more widespread depigmentation (BSA over 10%, P = 0.001). Extensive depigmentation was associated with reported triggering factors and mucosal involvement in both groups and with leukotrichia only in familial group. Widespread depigmentation related to the risk of presence of autoantibodies (P = 0.03) in sporadic cases of vitiligo (especially of PCA: P = 0.04 and ANA: P = 0.0002). Conclusions  In this study, we demonstrated first time that patients with familial vitiligo have a higher risk for vulgar type at the beginning of the disease and female gender increases the risk for more extensive depigmentation in sporadic cases.
doi_str_mv 10.1111/j.1468-3083.2011.04131.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1022259498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1022259498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4071-aa0da2e8a98e6d016569a193e5d24b3c24f4dd4343bf6fa9abdb702aac0937953</originalsourceid><addsrcrecordid>eNqNkMlOwzAQQC0EomX5BZQjlwRvWSzEAbEjKBJiu1mTeIxc0qbELbR_j0NLz_hiS_PeWHqERIwmLJyjYcJkVsSCFiLhlLGESiZYMt8g_fVgk_Sp4lmsVKp6ZMf7IaUBTYtt0uMs40Lxok-Oz5212OK4Qh-VOP1GHEcWRq52UEcwNpGfNC0YV0UV-MA0Nvpy0zB-b_bIloXa4_7q3iXPlxdPZ9fx3cPVzdnpXVxJmrMYgBrgWIAqMDOUZWmmgCmBqeGyFBWXVhojhRSlzSwoKE2ZUw5QUSVylYpdcrjcO2mbzxn6qR45X2FdwxibmdeMcs5TJVUR0GKJVm3jfYtWT1o3gnYRIN2l00PdFdJdId2l07_p9DyoB6tfZuUIzVr8axWAkyXw7Wpc_Huxvj1_6V7Bj5e-81Ocr31oP3SWizzVr4MrfU3vc_nGBvpR_ADXFIsx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1022259498</pqid></control><display><type>article</type><title>Differences between familial and sporadic cases of vitiligo</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Karelson, M. ; Silm, H. ; Salum, T. ; Kõks, S. ; Kingo, K.</creator><creatorcontrib>Karelson, M. ; Silm, H. ; Salum, T. ; Kõks, S. ; Kingo, K.</creatorcontrib><description>Background  Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history. Objective  The aim of our study was to describe differences between familial and sporadic cases of vitiligo. Methods  A total of 186 adult vitiligo patients were examined, in 173 of whom the level of thyroid peroxidase antibodies, gastric parietal cell antibodies (PCA), antinuclear antibodies (ANA), anti‐adrenal cortex antibodies and rheumatoid factor in blood was measured. All patients were divided in two groups: the cases with positive family history of vitiligo (51) and the sporadic cases (135). Results  The risk of onset of the disease up to 20 years of age was higher in the familial group (P = 0.008). Patients in familial group showed more widespread depigmentation compared with sporadic cases [body surface area (BSA) over 10%: P = 0.004; BSA over 50%: P = 0.001]. In familial group, patients had darker skin phototype (P = 0.045) and the disease had started more often as a vulgar vitiligo (P = 0.008). In sporadic vitiligo group, female gender was a risk factor for more widespread depigmentation (BSA over 10%, P = 0.001). Extensive depigmentation was associated with reported triggering factors and mucosal involvement in both groups and with leukotrichia only in familial group. Widespread depigmentation related to the risk of presence of autoantibodies (P = 0.03) in sporadic cases of vitiligo (especially of PCA: P = 0.04 and ANA: P = 0.0002). Conclusions  In this study, we demonstrated first time that patients with familial vitiligo have a higher risk for vulgar type at the beginning of the disease and female gender increases the risk for more extensive depigmentation in sporadic cases.</description><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/j.1468-3083.2011.04131.x</identifier><identifier>PMID: 21623928</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Autoantibodies - analysis ; Autoantibodies - immunology ; Child ; Child, Preschool ; Humans ; Middle Aged ; Vitiligo - diagnosis ; Vitiligo - genetics ; Vitiligo - immunology ; Young Adult</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2012-07, Vol.26 (7), p.915-918</ispartof><rights>2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology</rights><rights>2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4071-aa0da2e8a98e6d016569a193e5d24b3c24f4dd4343bf6fa9abdb702aac0937953</citedby><cites>FETCH-LOGICAL-c4071-aa0da2e8a98e6d016569a193e5d24b3c24f4dd4343bf6fa9abdb702aac0937953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1468-3083.2011.04131.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1468-3083.2011.04131.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21623928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karelson, M.</creatorcontrib><creatorcontrib>Silm, H.</creatorcontrib><creatorcontrib>Salum, T.</creatorcontrib><creatorcontrib>Kõks, S.</creatorcontrib><creatorcontrib>Kingo, K.</creatorcontrib><title>Differences between familial and sporadic cases of vitiligo</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><description>Background  Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history. Objective  The aim of our study was to describe differences between familial and sporadic cases of vitiligo. Methods  A total of 186 adult vitiligo patients were examined, in 173 of whom the level of thyroid peroxidase antibodies, gastric parietal cell antibodies (PCA), antinuclear antibodies (ANA), anti‐adrenal cortex antibodies and rheumatoid factor in blood was measured. All patients were divided in two groups: the cases with positive family history of vitiligo (51) and the sporadic cases (135). Results  The risk of onset of the disease up to 20 years of age was higher in the familial group (P = 0.008). Patients in familial group showed more widespread depigmentation compared with sporadic cases [body surface area (BSA) over 10%: P = 0.004; BSA over 50%: P = 0.001]. In familial group, patients had darker skin phototype (P = 0.045) and the disease had started more often as a vulgar vitiligo (P = 0.008). In sporadic vitiligo group, female gender was a risk factor for more widespread depigmentation (BSA over 10%, P = 0.001). Extensive depigmentation was associated with reported triggering factors and mucosal involvement in both groups and with leukotrichia only in familial group. Widespread depigmentation related to the risk of presence of autoantibodies (P = 0.03) in sporadic cases of vitiligo (especially of PCA: P = 0.04 and ANA: P = 0.0002). Conclusions  In this study, we demonstrated first time that patients with familial vitiligo have a higher risk for vulgar type at the beginning of the disease and female gender increases the risk for more extensive depigmentation in sporadic cases.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Autoantibodies - analysis</subject><subject>Autoantibodies - immunology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Vitiligo - diagnosis</subject><subject>Vitiligo - genetics</subject><subject>Vitiligo - immunology</subject><subject>Young Adult</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMlOwzAQQC0EomX5BZQjlwRvWSzEAbEjKBJiu1mTeIxc0qbELbR_j0NLz_hiS_PeWHqERIwmLJyjYcJkVsSCFiLhlLGESiZYMt8g_fVgk_Sp4lmsVKp6ZMf7IaUBTYtt0uMs40Lxok-Oz5212OK4Qh-VOP1GHEcWRq52UEcwNpGfNC0YV0UV-MA0Nvpy0zB-b_bIloXa4_7q3iXPlxdPZ9fx3cPVzdnpXVxJmrMYgBrgWIAqMDOUZWmmgCmBqeGyFBWXVhojhRSlzSwoKE2ZUw5QUSVylYpdcrjcO2mbzxn6qR45X2FdwxibmdeMcs5TJVUR0GKJVm3jfYtWT1o3gnYRIN2l00PdFdJdId2l07_p9DyoB6tfZuUIzVr8axWAkyXw7Wpc_Huxvj1_6V7Bj5e-81Ocr31oP3SWizzVr4MrfU3vc_nGBvpR_ADXFIsx</recordid><startdate>201207</startdate><enddate>201207</enddate><creator>Karelson, M.</creator><creator>Silm, H.</creator><creator>Salum, T.</creator><creator>Kõks, S.</creator><creator>Kingo, K.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201207</creationdate><title>Differences between familial and sporadic cases of vitiligo</title><author>Karelson, M. ; Silm, H. ; Salum, T. ; Kõks, S. ; Kingo, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4071-aa0da2e8a98e6d016569a193e5d24b3c24f4dd4343bf6fa9abdb702aac0937953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Autoantibodies - analysis</topic><topic>Autoantibodies - immunology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Vitiligo - diagnosis</topic><topic>Vitiligo - genetics</topic><topic>Vitiligo - immunology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karelson, M.</creatorcontrib><creatorcontrib>Silm, H.</creatorcontrib><creatorcontrib>Salum, T.</creatorcontrib><creatorcontrib>Kõks, S.</creatorcontrib><creatorcontrib>Kingo, K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karelson, M.</au><au>Silm, H.</au><au>Salum, T.</au><au>Kõks, S.</au><au>Kingo, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences between familial and sporadic cases of vitiligo</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2012-07</date><risdate>2012</risdate><volume>26</volume><issue>7</issue><spage>915</spage><epage>918</epage><pages>915-918</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><abstract>Background  Most cases of vitiligo are sporadic, but about 10–36% of the patients have positive family history. Objective  The aim of our study was to describe differences between familial and sporadic cases of vitiligo. Methods  A total of 186 adult vitiligo patients were examined, in 173 of whom the level of thyroid peroxidase antibodies, gastric parietal cell antibodies (PCA), antinuclear antibodies (ANA), anti‐adrenal cortex antibodies and rheumatoid factor in blood was measured. All patients were divided in two groups: the cases with positive family history of vitiligo (51) and the sporadic cases (135). Results  The risk of onset of the disease up to 20 years of age was higher in the familial group (P = 0.008). Patients in familial group showed more widespread depigmentation compared with sporadic cases [body surface area (BSA) over 10%: P = 0.004; BSA over 50%: P = 0.001]. In familial group, patients had darker skin phototype (P = 0.045) and the disease had started more often as a vulgar vitiligo (P = 0.008). In sporadic vitiligo group, female gender was a risk factor for more widespread depigmentation (BSA over 10%, P = 0.001). Extensive depigmentation was associated with reported triggering factors and mucosal involvement in both groups and with leukotrichia only in familial group. Widespread depigmentation related to the risk of presence of autoantibodies (P = 0.03) in sporadic cases of vitiligo (especially of PCA: P = 0.04 and ANA: P = 0.0002). Conclusions  In this study, we demonstrated first time that patients with familial vitiligo have a higher risk for vulgar type at the beginning of the disease and female gender increases the risk for more extensive depigmentation in sporadic cases.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21623928</pmid><doi>10.1111/j.1468-3083.2011.04131.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0926-9959
ispartof Journal of the European Academy of Dermatology and Venereology, 2012-07, Vol.26 (7), p.915-918
issn 0926-9959
1468-3083
language eng
recordid cdi_proquest_miscellaneous_1022259498
source MEDLINE; Access via Wiley Online Library
subjects Adolescent
Adult
Aged
Autoantibodies - analysis
Autoantibodies - immunology
Child
Child, Preschool
Humans
Middle Aged
Vitiligo - diagnosis
Vitiligo - genetics
Vitiligo - immunology
Young Adult
title Differences between familial and sporadic cases of vitiligo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A16%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20between%20familial%20and%20sporadic%20cases%20of%20vitiligo&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Karelson,%20M.&rft.date=2012-07&rft.volume=26&rft.issue=7&rft.spage=915&rft.epage=918&rft.pages=915-918&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/j.1468-3083.2011.04131.x&rft_dat=%3Cproquest_cross%3E1022259498%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1022259498&rft_id=info:pmid/21623928&rfr_iscdi=true